Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemorrhage 2Hematologic Neoplasms 2Thrombocytopenia 1Postoperative Hemorrhage 1Pelvic Mass 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Colonic Neoplasms 1Breast Neoplasms 1Breast Cancer Females 1Brain Neoplasms 1

Interventions

Tranexamic Acid 1Hemipelvectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Pelvic Mass × Tranexamic Acid × 1 year × Clear all
NCT03128866 2026-03-05

Tranexamic Acid in Reducing Blood Loss in Patients With Pelvic Tumors Undergoing Hemipelvectomy Surgery

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
80 enrolled

Pelvic Mass

Data powered by HemOnc (CC BY 4.0) Colophon âš¡